Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group.

Allory Y, Charlotte F, Benhamou Y, Opolon P, Le Charpentier Y, Poynard T.

Hum Pathol. 2000 Jan;31(1):69-74.

PMID:
10665916
2.

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group.

Benhamou Y, Bochet M, Di Martino V, Charlotte F, Azria F, Coutellier A, Vidaud M, Bricaire F, Opolon P, Katlama C, Poynard T.

Hepatology. 1999 Oct;30(4):1054-8.

PMID:
10498659
3.

Liver fibrosis progression in HIV/hepatitis C virus coinfected patients with normal aminotransferases levels.

Pace FH, Ferreira LE, Silva AE, Ferraz ML.

Rev Soc Bras Med Trop. 2012 Jul-Aug;45(4):444-7.

4.

Impact of early-untreated HIV infection on chronic hepatitis C in intravenous drug users: a case-control study.

Serfaty L, Costagliola D, Wendum D, Picard O, Meyohas MC, Girard PM, Lebas J, Delamare C, Poupon R, Housset C.

AIDS. 2001 Oct 19;15(15):2011-6.

PMID:
11600830
5.

HIV-HCV co-infected patients with low CD4+ cell nadirs are at risk for faster fibrosis progression and portal hypertension.

Reiberger T, Ferlitsch A, Sieghart W, Kreil A, Breitenecker F, Rieger A, Schmied B, Gangl A, Peck-Radosavljevic M.

J Viral Hepat. 2010 Jun;17(6):400-9. doi: 10.1111/j.1365-2893.2009.01197.x. Epub 2009 Sep 15.

PMID:
19780945
6.

Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.

Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.

J Viral Hepat. 2009 Nov;16(11):790-5. doi: 10.1111/j.1365-2893.2009.01133.x. Epub 2009 Apr 28.

PMID:
19413693
7.

The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.

Di Martino V, Rufat P, Boyer N, Renard P, Degos F, Martinot-Peignoux M, Matheron S, Le Moing V, Vachon F, Degott C, Valla D, Marcellin P.

Hepatology. 2001 Dec;34(6):1193-9.

PMID:
11732009
8.

Impaired CD4⁺ T cell stimulation of NK cell anti-fibrotic activity may contribute to accelerated liver fibrosis progression in HIV/HCV patients.

Glässner A, Eisenhardt M, Kokordelis P, Krämer B, Wolter F, Nischalke HD, Boesecke C, Sauerbruch T, Rockstroh JK, Spengler U, Nattermann J.

J Hepatol. 2013 Sep;59(3):427-33. doi: 10.1016/j.jhep.2013.04.029. Epub 2013 May 9.

PMID:
23665286
9.

Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.

Martinez-Sierra C, Arizcorreta A, Díaz F, Roldán R, Martín-Herrera L, Pérez-Guzmán E, Girón-González JA.

Clin Infect Dis. 2003 Feb 15;36(4):491-8. Epub 2003 Jan 31.

PMID:
12567308
10.

Influence of hepatitis C virus genotypes and HIV infection on histological severity of chronic hepatitis C. The Hepatitis/HIV Spanish Study Group.

García-Samaniego J, Soriano V, Castilla J, Bravo R, Moreno A, Carbó J, Iñiguez A, González J, Muñoz F.

Am J Gastroenterol. 1997 Jul;92(7):1130-4.

PMID:
9219784
11.

Progression of liver fibrosis in monoinfected patients by hepatitis C virus and coinfected by HCV and human immunodeficiency virus.

Tovo CV, Becker SC, Almeida PR, Galperim B, Chaves S.

Arq Gastroenterol. 2013 Jan-Mar;50(1):19-22.

12.

Fibrosis is worse in HIV-HCV patients with low-level immunodepression referred for HCV treatment than in HCV-matched patients.

Rullier A, Trimoulet P, Neau D, Bernard PH, Foucher J, Lacoste D, Winnock M, Urbaniak R, Ballardini G, Balabaud C, Bioulac-Sage P, Le Bail B.

Hum Pathol. 2004 Sep;35(9):1088-94.

PMID:
15343510
13.

Impact of antiretroviral treatment on progression of hepatic fibrosis in HIV/hepatitis C virus co-infected patients.

Mariné-Barjoan E, Saint-Paul MC, Pradier C, Chaillou S, Anty R, Michiels JF, Sattonnet C, Ouzan D, Dellamonica P, Tran A; Registre des Ponctions-Biopsies Hépatiques.

AIDS. 2004 Nov 5;18(16):2163-70.

PMID:
15577649
14.

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy.

Benhamou Y, Di Martino V, Bochet M, Colombet G, Thibault V, Liou A, Katlama C, Poynard T; MultivirC Group.

Hepatology. 2001 Aug;34(2):283-7.

PMID:
11481613
15.

Clinical and epidemiological features of patients with chronic hepatitis C co-infected with HIV.

Braga EL, Lyra AC, Ney-Oliveira F, Nascimento L, Silva A, Brites C, Marbak R, Lyra LG.

Braz J Infect Dis. 2006 Feb;10(1):17-21. Epub 2006 Jun 2.

16.

Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients.

Mohsen AH, Easterbrook PJ, Taylor C, Portmann B, Kulasegaram R, Murad S, Wiselka M, Norris S.

Gut. 2003 Jul;52(7):1035-40.

17.

There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV.

Souza AR, Tovo CV, Mattos AA, Chaves S.

Braz J Med Biol Res. 2008 Mar;41(3):223-8. Epub 2007 Dec 20.

18.
19.

Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.

Barreiro P, Martín-Carbonero L, Núñez M, Rivas P, Morente A, Simarro N, Labarga P, González-Lahoz J, Soriano V.

Clin Infect Dis. 2006 Apr 1;42(7):1032-9. Epub 2006 Feb 21.

PMID:
16511772
20.

Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.

Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E.

Clin Infect Dis. 2006 Sep 1;43(5):640-4. Epub 2006 Jul 27.

PMID:
16886160

Supplemental Content

Support Center